ALNT ALLIENT INC 10-Q 2026-09-30 section summaries

An AI model summarized each section of the report on its own; the summary was written from these. They are longer and less edited than the summary, and the filing on SEC is the authority.

Item 1, Financial Statements

Allient Inc. (ALNT) — nine months ended September 30, 2026

Unaudited; amounts in USD unless stated.

Consolidated results

$ millions, except per-share data Q3 2026 Q3 2025 9M 2026 9M 2025
Revenue $164.399 $138.743 $457.084 $411.124
Cost of goods sold 104.214 92.562 297.932 275.835
Gross profit 60.185 46.181 159.152 135.289
Operating expenses 37.885 34.001 111.921 102.653
Operating income 22.300 12.180 47.231 32.636
Interest expense 2.494 3.401 7.570 10.588
Net income 15.325 6.477 31.073 15.651
Diluted EPS $0.91 $0.39 $1.84 $0.94

Q3 revenue grew 18.5% year over year, and operating margin improved to 13.6% from 8.8%; gross margin increased to 36.6% from 33.3%. Nine-month revenue grew 11.2%. Lower interest expense also supported earnings growth. Restructuring and business realignment costs were $1.518 million for 9M 2026, compared with $3.457 million in 9M 2025.

Revenue by target market and geography

Allient reports one operating segment, specialty-controlled motion products and solutions. The following breakdowns show revenue by end market and shipment geography.

Target market revenue, $ millions Q3 2026 Q3 2025 9M 2026 9M 2025
Industrial $81.694 $71.023 $225.730 $198.904
Vehicle 27.310 21.584 76.898 71.278
Medical 21.299 21.656 62.604 60.803
Aerospace & Defense 25.493 18.755 70.199 60.753
Distribution and Other 8.603 5.725 21.653 19.386

Vehicle growth accelerated in Q3 relative to 9M, while Medical revenue declined in Q3 despite 9M growth. Aerospace & Defense and Distribution and Other also grew faster in Q3 than for the first nine months.

Geographic revenue, $ millions Q3 2026 Q3 2025 9M 2026 9M 2025
North America $114.786 $94.838 $306.053 $273.463
Europe 44.235 37.470 133.384 118.517
Asia-Pacific 5.378 6.435 17.647 19.144

North America and Europe grew faster in Q3 than over 9M; Asia-Pacific declined in both periods. U.S. customers represented 57% of revenue in both Q3 periods and 55% in both 9M periods. No customer individually represented a material concentration of revenue or receivables.

Balance sheet and cash flow

Balance sheet, $ millions Sep. 30, 2026 Dec. 31, 2025
Total assets $614.738 $577.595
Total stockholders’ equity 327.216 301.455
Goodwill 133.137 134.332
Intangible assets, net (excluding goodwill) 78.403 88.391
— Customer lists 52.416 58.921
— Trade name 5.922 6.634
— Design and technologies 20.065 22.836
Cash 39.646 40.705
Long-term debt, carrying value 173.372 180.389
Receivables 109.633 88.775
Inventory 126.966 109.198
Shares outstanding, millions 16.989 16.936

Tangible common equity (equity less goodwill and other intangible assets) was $115.676 million, up from $78.732 million. Goodwill decreased primarily due to $1.195 million of foreign-currency translation. Inventory comprised $92.566 million of parts and raw materials, $15.154 million of work-in-process, and $19.246 million of finished goods. Net PP&E was $63.191 million, versus $61.771 million.

Cash flow, $ millions 9M 2026 9M 2025
Operating cash flow $22.084 $43.116
Capital expenditures 10.640 5.090
Derived free cash flow 11.444 38.026

Cash generation fell despite higher net income, mainly as receivables used $22.137 million of cash versus $10.679 million in 9M 2025, and inventory used $21.026 million versus being a $1.863 million source. Depreciation was $9.122 million versus $9.755 million. Allient paid $9.343 million of long-term debt and finance-lease principal, $1.848 million in dividends, and $7.227 million of cash interest during 9M 2026.

Funding, operations, and other developments

Long-term debt included $117.962 million outstanding on the revolving facility, a $50.000 million note payable, $1.852 million of unamortized issuance costs, and $7.262 million of noncurrent finance-lease obligations. The revolving balance declined from $124.962 million; the note remained $50.000 million. The $280 million revolver matures March 1, 2029 and has a $50 million accordion; unused capacity was $162.038 million, subject to covenants. The Series A notes mature in 2031 and bear 5.96% interest; the effective rate on long-term debt was 4.99%. Covenants require at least 3.0:1.0 interest coverage and, after 2025, no more than 3.75:1.0 leverage; the company reported compliance. Debt is secured by substantially all non-real-estate assets.

Under its “Simplify to Accelerate NOW” strategy, Allient is establishing a Fabrication Center of Excellence in Dothan, Alabama, while transferring assembly operations to Tulsa, Oklahoma, and Reynosa, Mexico. Approximately $2 million of 2026 one-time costs, primarily severance and personnel expenses, were anticipated; the restructuring accrual was zero at September 30 after quarterly cash payments.

Stock-based compensation expense was $2.829 million for 9M 2026 versus $2.590 million; 209,468 unvested awards remained, down from 234,370 at the start of the period. Allient awarded 108,272 restricted shares at a weighted-average market value of $63.11 per share. The quarterly dividend rose to $0.04 per share in Q2 and Q3 2026 from $0.03 in each 2025 quarter.

Foreign-currency contracts had $41.758 million notional at period-end and generated losses of $0.895 million in 9M 2026. Cash-flow-hedge swaps had $40 million notional maturing in December 2026 and $50 million maturing in September 2027; $0.765 million was expected to be reclassified from accumulated OCI to reduce interest expense over the next 12 months. Foreign-currency translation generated a $5.206 million loss in 9M 2026, compared with a $14.121 million gain in 9M 2025; accumulated OCI was a $14.580 million loss at September 30. The effective tax rate was 22.2% in Q3 and 21.3% for 9M, versus 22.1% for 9M 2025.

Operating-lease liabilities were $25.852 million and finance-lease liabilities $7.757 million at September 30. Certain facility leases are with entities partly owned by a member of management; future fixed minimum payments on those leases totaled $4.413 million. Contract assets were $1.000 million and contract liabilities $3.599 million; $1.789 million of 9M 2026 revenue had been included in opening contract liabilities.

Item 2, Management's Discussion and Analysis of Financial Condition and Results of Operations

ALNT — MD&A summary

Results

Metric Q3 2026 Q3 2025 9M 2026 9M 2025
Revenue $164.399M $138.743M $457.084M $411.124M
Cost of goods sold $104.214M $92.562M $297.932M $275.835M
Gross profit $60.185M $46.181M $159.152M $135.289M
Gross margin 36.6% 33.3% 34.8% 32.9%
Operating expenses $37.885M $34.001M $111.921M $102.653M
Operating income $22.300M $12.180M $47.231M $32.636M
Net income $15.325M $6.477M $31.073M $15.651M
Diluted EPS $0.91 $0.39 $1.84 $0.94

Q3 revenue grew 18.5%; growth was driven by a 19.1% volume increase, partly offset by a 0.6% unfavorable currency impact. For 9M, revenue grew 11.2%, reflecting 9.8% volume growth and a 1.4% favorable currency impact. Sales were primarily to U.S. customers (57% in Q3 and 55% for 9M), with the balance mainly to Europe, Canada, and Asia-Pacific.

Gross margin expansion and higher sales drove improved operating income and net income, partly offset by higher operating expenses. Q3 expense growth included higher personnel costs, commissions, marketing, software licensing, and IT consulting; cost reductions partly offset higher engineering costs. For 9M, selling expense was $22.030M versus $18.257M, G&A was $48.421M versus $42.364M, and engineering and development was $30.579M versus $29.185M. Restructuring and business realignment expense declined to $1.518M from $3.457M. Interest expense also declined, to $2.494M from $3.401M in Q3 and $7.570M from $10.588M for 9M, primarily due to lower average debt balances.

Non-GAAP / supplemental earnings Q3 2026 Q3 2025 9M 2026 9M 2025
Adjusted net income $18.007M $9.885M $39.977M $27.003M
Adjusted diluted EPS $1.07 $0.59 $2.37 $1.61
EBITDA $28.284M $18.146M $65.563M $49.777M
Adjusted EBITDA $29.652M $20.299M $70.642M $57.838M

Adjusted earnings exclude items including intangible-asset amortization, foreign-currency effects, and restructuring costs. The effective tax rate was 22.2% in both Q3 periods and 21.3% for 9M 2026 versus 22.1% in 9M 2025; management expects a full-year 2026 rate of approximately 21%–23%.

Demand and operating developments

Metric Q3 2026 Q3 2025 9M 2026 9M 2025
Bookings $218.057M $133.119M $577.434M $405.774M
Backlog, period end $351.489M $230.984M — —

Bookings volume increased 64.4% in Q3 and 40.9% for 9M. The backlog comparison indicates a substantial year-over-year increase, though conversion timing remains uncertain. Industrial and Aerospace & Defense were the strongest areas of revenue growth.

The Simplify to Accelerate NOW program is reorganizing manufacturing and streamlining operations to improve efficiency, profitability, and flexibility, with additional annualized savings expected in 2026. ALNT is transferring Dothan, Alabama assembly operations to Tulsa, Oklahoma, and Reynosa, Mexico, while developing Dothan as a Fabrication Center of Excellence for precision applications including aerospace and defense, medical, and electronic test and assembly. Restructuring costs were approximately $4M in 2025; 9M 2026 costs were $1.518M, including $15K in Q3, and approximately $2M is expected for full-year 2026, substantially paid by year-end. The company is also seeking to expand Controls and Power alongside Motion, organically and through acquisitions.

Cash flow, liquidity, and capital allocation

Cash flow / investment 9M 2026 9M 2025
Operating cash flow $22.084M $43.116M
Property-and-equipment purchases (capital expenditures) $10.640M $5.090M
Net investing cash outflow $10.640M $5.090M
Net financing cash outflow $11.899M $36.997M
Net debt repayments $7.343M —
Net change in cash $(1.059)M $3.374M increase

Lower cash inflows from accounts-receivable collections and inventory payments contributed to the decline in operating cash flow, partly offset by higher net income, noncash items, and accounts-payable timing. Full-year 2026 capital expenditures are expected to be $12M–$15M. Cash and cash equivalents were $39.646M at September 30, 2026, down $1.059M from December 31, 2025; $36.855M was held at foreign subsidiaries and may incur withholding tax if repatriated to the U.S.

Revolving Facility obligations were $117.962M, excluding deferred financing costs, with $162.038M unused. Availability may be constrained by debt, EBITDA, and covenant calculations. The revolver matures March 1, 2029; Series A Senior Notes are due March 21, 2031, and their interest rate has returned to 5.960%. Debt agreements require at least a 3.0:1.0 interest coverage ratio and generally cap leverage at 3.75:1.0; ALNT was in compliance at September 30, 2026. Dividends declared were $0.11 per share for 9M 2026 versus $0.09 in 9M 2025. Management expects operating cash and available credit to fund working capital, capital expenditures, and dividends, and believes liquidity is sufficient for ordinary-course needs over the next 12 months.

Risks and uncertainties

Geopolitical conflict and changing trade policies create uncertainty around energy prices, interest rates, supply chains, tariffs, and customer ordering; ALNT manufactures in Mexico, China, and Europe and sources components from potentially affected locations. After a February 2026 Supreme Court ruling invalidated certain IEEPA-based tariffs assessed in 2025, the company was pursuing refunds: $651K had been approved and $273K received as of September 30, 2026. Other risks include demand and backlog conversion, customer concentration or loss, supplier availability, competition and technology change, cybersecurity and IT disruption, skilled-personnel retention, and acquisition integration.

Item 3, Quantitative and Qualitative Disclosures About Market Risk

Foreign-exchange risk

For the nine months ended September 30, 2026, foreign-exchange movements increased revenue by $5.491 million. A hypothetical 10% movement in the U.S. dollar against the company’s main currency exposures would have affected nine-month sales by approximately $15.855 million. This is not an estimate of the effect on net earnings, because costs and operating expenses in those currencies provide partial offsets. A similar 10% move against foreign net assets would have affected their value by approximately $20.748 million at September 30, 2026.

FX-related item Q3 2026 Q3 2025 9M 2026 9M 2025
Translation adjustments $(0.689)M $(1.385)M $(5.206)M $14.121M
Net FX transaction losses in other expense — — $0.733M loss $1.974M loss
Foreign-currency contract losses $0.228M — $0.895M —

Translation adjustments, which relate to permanent investments in foreign subsidiaries, are recorded in comprehensive income. Foreign-currency contracts had $41.758 million of notional value at September 30, 2026, and primarily hedged short-term balance-sheet exposures, mainly intercompany balances. Contract losses generally offset FX gains or losses on the related balances.

Interest-rate risk and debt hedging

The Series A Notes bear a fixed 5.96% rate and mature on March 21, 2031. An amendment set the rate at 6.46% from October 1, 2024 through September 30, 2025. Credit Facility pricing is Term SOFR plus 1.25%–2.50%; the margin was 1.625% at September 30, 2026, compared with 2.50% from January 1 through September 30, 2025.

The company had interest-rate swaps with notionals of $40 million and $50 million, maturing in December 2026 and September 2027, respectively. At September 30, 2026, revolving borrowings were $117.962 million, excluding deferred financing fees; $90 million was hedged, leaving $27.962 million unhedged and floating-rate. A hypothetical 100-basis-point change in the Base Rate on that unhedged balance would have affected interest expense by approximately $0.210 million for 9M 2026.

Item 4, Controls and Procedures

As of September 30, 2026, management, including the CEO and CFO, concluded that the company’s disclosure controls and procedures were effective. During Q3 2026, no changes in internal control over financial reporting materially affected, or were reasonably likely to materially affect, those controls.

Part II Item 1A, Risk Factors

Risk Factors

The company reported no material changes to the risk factors disclosed in its Form 10-K for the year ended December 31, 2025, except that information elsewhere in this Form 10-Q may relate to those risks. For the full discussion, see Item 1A of the 2025 Annual Report and Form 10-K.

Part II Item 5, Other Information

For the quarter ended September 30, 2026, none of ALNT’s directors or executive officers adopted or terminated a Rule 10b5-1 or non-Rule 10b5-1 trading arrangement.

Feedback